AB680
potent, selective, Q2W IV CD73 inhibitor completed Ph. I in HV, in dev. for cancer imm. from opt. of known nucleotide CD73 inh. J. Med. Chem., Jul. 20, 2020 Arcus Biosciences, Hayward, CA
Molecules of the Month - July 2020
Molecules of the Month
- A-1331852
- dotinurad (FYU-981)
- X-165
- "compound 38a"
- HTL22562
- "compound 23"
- MGS0274
- LXE408
- "compound 2"
- AB680
- "compound 18"
- ETX0282
- "compound 6g"
- EC2629